FDA Officials Discuss Overhauling Agency In NEJM Perspective

Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Public Health
Article Date: 27 May 2009 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

"The FDA as a Public Health Agency," New England Journal of Medicine: In the perspective, FDA Commissioner Margaret Hamburg and Joshua Sharfstein, principal deputy commissioner of the agency, provide "a broad overview" of how they plan to "embrace" the agency's mission to protect the public's health. Hamburg and Sharfstein discuss their plans to work with other U.S. agencies, such as NIH, CDC and CMS, as well as challenges posed by globalization. In addition, they write that they will work to improve transparency at FDA (Hamburg/Sharfstein, NEJM, 5/26).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.